Wen Liu,Adam Robert Mezo,Francisco Alcides Valenzuela
申请号：
US15983167
公开号：
US10400021B2
申请日:
2018.05.18
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The presently described compounds relate to the treatment of diabetes and/or hyperglycemia. More particularly, the described compounds relate to acylated insulin compounds that lower blood glucose, pharmaceutical compositions containing such compounds, therapeutic uses of such compounds, and an intermediate compound used to make the acylated insulin compounds.
